MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517017391 A) filed by Alivexis, Inc., Tokyo, on Feb. 27, for 'kit inhibitors, compounds, pharmaceutical compositions, and methods of use thereof.'
Inventor(s) include Takahashi Taisuke; Shimizu Takafumi; Terada Yoh; Urakami Takeo; Sinko William; Poddutoori Ramulu; and Gummadi Venkateshwar Rao.
The application for the patent was published on May 2, under issue no. 18/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are compounds and compositions useful in inhibiting a receptor tyrosine kinase, KIT. The compounds and compositions provided herein are useful for the prevention or treatment of one or more KIT...